Post-cesarean Pain Control Via Continuous Infusion of Ropivacain et Diclogenac Into the Wound Ver… (NCT01211431) | Clinical Trial Compass
WithdrawnPhase 4
Post-cesarean Pain Control Via Continuous Infusion of Ropivacain et Diclogenac Into the Wound Versus Intathecal Morphine
Stopped: No inclusions.
0Started 2010-09
Plain-language summary
The goal is to compare the quality of post-cesarean analgesia, the side effects and the incidence of residual scar pain obtained with intrathecal morphine (reference treatment) or with a continuous intra-wound solution including both ropivacain and diclofenac (experimental treatment).
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* single, normally progressing pregancy
* term \> 36 weeks amenorrhea
* BMI between 20 and 25 kg/m\^2 before pregnancy
* height between 55 and 90 kg
* cesarean section by Joel-Cohen or Pfannenstiel techniques
* patient has signed consent
* patient has social security coverage
Exclusion Criteria:
* Multiple pregnancy
* pathological pregnancy: hypertension (\>140/90 mmHg found during the pregnancy), pre-eclampsia, gestational diabetes
* term \< 36 weeks amenorrhea
* non-pregnancy related maternal pathology (insufficiency)
* obesity (BMI \> 25 kg/m\^2 before pregnancy)
* height \< 155 cm or \> 180 cm
* weight \< 55 kg or \> 90 kg
* patient refuses to sign consent
* surgical technique other than Joel-Cohen or Pfannenstiel
* hepatic insufficiency (prothrombin \< 60%)
* contra-indications for rachianesthesia: infection, hemostasis problems (platelets \< 80.109/L, prothrombin \< 60%, TCA \> 40s)
* allergy to local anesthestics
* patient is participating in another study, or has participated in another study within the last 6 months
* patient is under any type of guardianship
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.